D
Drugs Made In America Acquisition Corp
NASDAQ:DMAA
Drugs Made In America Acquisition Corp
NASDAQ:DMAA
Price:
10.515
USD
Market Closed
Market Cap:
$352.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
Eiffage SA
OTC:EFGSY
|
FR |
|
M
|
Max Heights Infrastructure Ltd
BSE:534338
|
IN |
Drugs Made In America Acquisition Corp
Other Items
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Drugs Made In America Acquisition Corp
Other Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
Drugs Made In America Acquisition Corp
NASDAQ:DMAA
|
Other Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
WP Carey Inc
NYSE:WPC
|
Other Items
$888.4m
|
CAGR 3-Years
65%
|
CAGR 5-Years
22%
|
CAGR 10-Years
30%
|
|
|
AltC Acquisition Corp
NYSE:OKLO
|
Other Items
-$456.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Annaly Capital Management Inc
NYSE:NLY
|
Other Items
-$26.5B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ares Capital Corp
NASDAQ:ARCC
|
Other Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
SoFi Technologies Inc
NASDAQ:SOFI
|
Other Items
-$6.5B
|
CAGR 3-Years
-1 255%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
No Stocks Found
Drugs Made In America Acquisition Corp
Glance View
Drugs Made In America Acquisition Corp. is a blank check company. The company is headquartered in Fort Lauderdale, Florida. The company went IPO on 2025-01-28. The firm is incorporated as an exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. Its efforts to identify a prospective target business will not be limited to a particular industry or geographic region although it intends to focus its search for business combination targets in the pharmaceutical industry.
DMAA
Intrinsic Value
Not Available
D
